InspireMD Q4 2024 GAAP EPS $(0.19) Beats $(0.20) Estimate, Sales $1.95M Beat $1.82M Estimate

Author: Benzinga Newsdesk | March 12, 2025 06:04am
InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) by 5 percent. This is a 18.75 percent decrease over losses of $(0.16) per share from the same period last year. The company reported quarterly sales of $1.95 million which beat the analyst consensus estimate of $1.82 million by 7.29 percent. This is a 10.68 percent increase over sales of $1.76 million the same period last year.

Posted In: NSPR